Ye Ni, Wang Bin, Quan Zi-Fang, Cao San-Jie, Wen Xin-Tian, Huang Yong, Huang Xiao-Bo, Wu Rui, Ma Xiao-Ping, Yan Qi-Gui
College of Veterinary Medicine, Sichuan Agricultural University, Yaan, Sichuan, China E-mail :
Asian Pac J Cancer Prev. 2014;15(15):5993-7. doi: 10.7314/apjcp.2014.15.15.5993.
The discovery of long noncoding RNA (LncRNA) changes our view of transcriptional and posttranscriptional regulation of gene expression. With application of new research techniques such as high-throughput sequencing, the biological functions of LncRNAs are gradually becoming to be understood. Multiple studies have shown that LncRNAs serve as carcinogenic factors or tumor suppressors in breast cancer with abnormal expression, prompts the question of whether they have potential value in predicting the stages and survival rate of breast cancer patients, and also as therapeutic targets. Focusing on the latest research data, this review mainly summarizes the tumorigenic mechanisms of certain LncRNAs in breast cancer, in order to provide a theoretical basis for finding safer, more effective treatment of breast cancer at the LncRNA molecular level.
长链非编码RNA(LncRNA)的发现改变了我们对基因表达转录和转录后调控的看法。随着高通量测序等新研究技术的应用,LncRNAs的生物学功能逐渐被人们所了解。多项研究表明,LncRNAs在乳腺癌中作为致癌因子或肿瘤抑制因子表达异常,这引发了它们在预测乳腺癌患者分期和生存率方面是否具有潜在价值的问题,同时也可作为治疗靶点。基于最新的研究数据,本综述主要总结了某些LncRNAs在乳腺癌中的致瘤机制,以便为在LncRNA分子水平上寻找更安全、更有效的乳腺癌治疗方法提供理论依据。